Keyphrases
Pediatric
80%
Seizure
56%
N-methyl-D-aspartate Receptor (NMDAR)
48%
Encephalitis
46%
Autoantibodies
42%
Autoimmune Encephalitis
39%
Acquired Demyelinating Syndromes
36%
Epileptic Encephalopathy
33%
LGI1
31%
Antibody-mediated
30%
Epilepsy
30%
MOG-Ab
28%
Clinical Features
26%
N-methyl-D-aspartate Receptor Antibody
24%
Aquaporin-4 (AQP4)
24%
Onconeural Antibodies
23%
Autoimmune
23%
Magnetoencephalography
23%
Acute Disseminated Encephalomyelitis
23%
CASPR2
21%
Multiple Sclerosis
20%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
18%
Disease Course
18%
Rodent Models
17%
Myelin Oligodendrocyte Glycoprotein Antibody
16%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
16%
VGKC-complex
15%
Brain Networks
15%
Epileptic Seizure
14%
Myelin Oligodendrocyte Glycoprotein
14%
Central Nervous System
14%
Surveillance Studies
13%
Pediatric Autoimmune Encephalitis
13%
Acquired Demyelinating Disease
13%
Disease-modifying Therapy
13%
Patient-derived
13%
Encephalopathy
12%
Early Treatment
12%
Paraclinical
12%
AMPA Receptor (AMPAR)
11%
Demyelinating Diseases
11%
Optic Neuritis
11%
Pediatric Epilepsy
10%
Epileptiform Activity
10%
VGKC Antibody
10%
Antibody-negative
10%
Mouse Model
10%
Passive Transfer
10%
Autoimmune Epilepsy
10%
Pediatric multiple Sclerosis
10%
Neuroscience
Encephalitis
75%
Brain Disease
49%
Autoantibodies
45%
Myelin Oligodendrocyte Glycoprotein
42%
Immunotherapy
39%
Receptor Antibody
32%
Aspartic Acid
32%
In Vivo
30%
Receptor
30%
Leucine
27%
Contactin
26%
Magnetoencephalography
23%
In Vitro
22%
Multiple Sclerosis
21%
Central Nervous System
19%
Demyelinating Disease
18%
Nervous System Disorder
18%
Brain Network
17%
Acute Disseminated Encephalomyelitis
16%
Dextro Aspartic Acid
16%
Magnetic Resonance Imaging of Brain
15%
Magnetic Resonance Imaging
14%
Behavior (Neuroscience)
13%
Optic Neuritis
11%
AMPA Receptor
11%
Status Epilepticus
11%
Pediatric Epilepsy
10%
Limbic Encephalitis
10%
Neuromyelitis Optica
10%
Synaptic Transmission
10%
Axonin 1
10%
Voltage-Gated Potassium Channel
10%
Aquaporin 4 Antibody
10%
Expanded Disability Status Scale
10%
Ictal
9%
Neurosteroid
9%
Stereotypic Movement Disorder
9%
Neurophysiology
8%
Cognitive Disorders
8%
Epileptic Seizure
8%
Immune System Disorders
7%
Focal Epilepsy
7%
Intravenous Immunoglobulin
7%
Immunoglobulin G
6%
Electrophysiology
6%
Nerve Fiber
6%
Synapsin I
6%
Receptor Protein
6%
Relapsing Remitting Multiple Sclerosis
6%
Autoantigen
6%
Medicine and Dentistry
Pediatrics
100%
Epileptic Seizure
35%
Brain Disease
35%
Multiple Sclerosis
32%
Acute Disseminated Encephalomyelitis
23%
Diseases
23%
Myelin Oligodendrocyte Glycoprotein
23%
Aquaporin 4 Antibody
22%
Immunotherapy
21%
Autoantibodies
21%
Encephalitis
19%
Allergic Encephalitis
19%
Clinical Feature
18%
Autoimmunity
17%
Disease Course
17%
Magnetoencephalography
17%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
15%
Receptor Antibody
15%
Magnetic Resonance Imaging
15%
Clinically Isolated Syndrome
14%
Central Nervous System
12%
Contactin
11%
Neuromyelitis Optica
10%
Dextro Aspartic Acid
10%
N Methyl-D-Aspartate Receptor
10%
Paraneoplastic Cerebellar Degeneration
10%
Ganglioglioma
10%
Leucine
10%
Partial Seizure
9%
Pediatric Neurology
9%
Transverse Myelitis
9%
Voltage-Gated Potassium Channel
8%
Magnetic Resonance Imaging of Brain
8%
AMPA Receptor
8%
Recurrent Disease
7%
Onset Age
7%
Neurologic Disease
6%
MOG Antibody Disease
6%
School-Age Children
6%
Treatment Response
6%
Brain Tissue
6%
Autoantigen
6%
Endocrine Disease
6%
Epileptiform Activity
6%
Psychological Outcome
6%
Basal Ganglia
6%
Disease Modifying Therapy
6%
Combination Therapy
6%
Clinical Research
6%
Cognitive Function
6%
